Artificial Intelligence for Early Detection and Prognosis Prediction of Diabetic Retinopathy
Description
This review explores the transformative role of artificial intelligence (AI) in the early detection and prognosis prediction of diabetic retinopathy (DR), a leading cause of vision loss in diabetic patients. AI, particularly deep learning and convolutional neural networks (CNNs), has demonstrated remarkable accuracy in analyzing retinal images, identifying early-stage DR with high sensitivity and specificity. These advancements address critical challenges such as intergrader variability in manual screening and the limited availability of specialists, especially in underserved regions. The integration of AI with telemedicine has further enhanced accessibility, enabling remote screening through portable devices and smartphone-based imaging. Economically, AI-based systems reduce healthcare costs by optimizing resource allocation and minimizing unnecessary referrals. Key findings highlight the dominance of Medicine (819 documents) and Computer Science (613 documents) in research output, reflecting the interdisciplinary nature of this field. Geographically, China, the United States, and India lead in contributions, underscoring global efforts to combat DR. Despite these successes, challenges such as algorithmic bias, data privacy, and the need for explainable AI (XAI) remain. Future research should focus on multi-center validation, diverse AI methodologies, and clinician-friendly tools to ensure equitable adoption. By addressing these gaps, AI can revolutionize DR management, reducing the global burden of diabetes-related blindness through early intervention and scalable solutions.
Files
Steps to reproduce
This study adopted a rigorous systematic bibliometric analysis following the PRISMA framework to investigate the application of artificial intelligence in diabetic retinopathy detection and prognosis prediction. The research methodology was designed to provide both quantitative and qualitative insights through multiple phases of data collection, screening, and analysis. We utilized Scopus as our primary database, focusing on journal articles published between 2022 and 2025 in computer science and medicine, to ensure we captured the most recent and relevant advancements in this rapidly evolving field. Our comprehensive search strategy incorporated three key thematic areas: AI methodologies, diabetic retinopathy terminology, and clinical applications, which yielded an initial pool of 5,878 records. The screening process followed strict PRISMA guidelines, beginning with duplicate removal before progressing through title/abstract screening and full-text evaluation conducted by independent reviewers. This meticulous approach resulted in 912 high-quality articles selected for in-depth analysis, with careful documentation of exclusion criteria at each stage to maintain transparency. For the bibliometric analysis, we employed a suite of specialized tools including VOSviewer for network visualization and science mapping, Harzing's Publish or Perish for citation analysis, and Microsoft Excel for data organization and trend analysis. These tools enabled us to conduct performance analyses of publication patterns, science mapping of conceptual domains, and content analysis of AI techniques and clinical applications. To ensure methodological rigor, we implemented several quality assurance measures such as inter-rater reliability checks, search string validation, and peer debriefing. Our analytical approach combined quantitative metrics like citation counts and author productivity with qualitative assessments of research themes and methodological quality. The visual representation of our methodology through the PRISMA flow diagram effectively communicated our systematic literature selection process, while the multi-dimensional analysis framework provided both macro-level patterns and micro-level insights. This comprehensive approach not only mapped the current state of knowledge in AI applications for diabetic retinopathy but also identified significant gaps and opportunities for future research, offering valuable insights for researchers and clinicians working at the intersection of artificial intelligence and ophthalmology.
Institutions
- Cyberjaya University College of Medical Sciences